Endogenous regenerative technology using plasma- and platelet-derived growth factors

Journal of Controlled Release

Volumn 157, Issue 3, 2012, Pages 317-320

  Anitua, Eduardo ^a,b   Orive, Gorka ^a,b  

^a Biotechnology Institute BTI   (Spain)

^b Biotechnology Institute (BTI)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BIOMATERIAL; COLLAGEN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GELATIN; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; POLYGLACTIN; SCATTER FACTOR; SOMATOMEDIN C; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CHONDROCYTE IMPLANTATION; FIBROBLAST; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TENDON INJURY; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; WOUND HEALING;

EID: 84857358094     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.11.011     Document Type: Article

References (52)

1. O. Capi, and L. Gepstein Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes J. Control. Release 116 2006 211 221
2. D.E. Discher, D.J. Mooney, and P.W. Zandstra Growth factors, matrices, and forces combine and control stem cells Science 324 2009 1673 1677
3. G. Orive, E. Anitua, J.L. Pedraz, and D.F. Emerich Biomaterials for promoting brain protection, repair and regeneration Nat. Rev. Neurosci. 10 2009 682 692
4. Y. Xie, Z. Upton, S. Richards, S.C. Rizzi, and D.I. Leavesle Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin: growth factor complexes in wound healing applications J. Control. Release 153 2011 225 232
5. P. Macchiarini, P. Jungebluth, T. Go, M.A. Asnaghi, L.E. Rees, T.A. Cogan, A. Dodson, J. Martorell, S. Bellini, P.P. Parnigotto, S.C. Dickinson, A.P. Hollander, S. Mantero, M.T. Conconi, and M.A. Birchall Clinical transplantation of a tissue-engineered airway Lancet 372 2008 2023 2030
6. G. Orive, R.M. Hernández, A.R. Gascón, R. Calafiore, T.M. Chang, P. De Vos, G. Hortelano, D. Hunkeler, I. Lacík, A.M. Shapiro, and J.L. Pedraz Cell encapsulation: promise and progress Nat. Med. 9 2003 104 107 (Pubitemid 36098269)
7. G. Orive, M. De Castro, H.J. Kong, R.M. Hernández, S. Ponce, D.J. Mooney, and J.L. Pedraz Bioactive cell-hydrogel microcapsules for cell-based drug delivery J. Control. Release 135 2009 203 210
8. S. Huang, and X. Fu Naturally derived materials-based cell and drug delivery systems in skin regeneration J. Control. Release 142 2010 149 159
9. N. Cuende, and A. Izeta Clinical translation of stem cell therapies: a bridgeable gap Cell Stem Cell 6 2010 508 512
10. G.Q. Daley Stem cells: roadmap to the clinic J. Clin. Invest. 120 2010 8 10
11. D.J. Prockop Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms Mol. Ther. 17 2009 939 946
12. E. Anitua, M. Sánchez, G. Orive, and I. Andía Delivering growth factors for therapeutics Trends Pharmacol. Sci. 1 2008 37 41
13. E. Anitua, M. Sánchez, and G. Orive Potential of endogenous regenerative technology for in situ regenerative medicine Adv. Drug Deliv. Rev. 62 2010 741 752
14. E. Anitua, M.H. Alkhraisat, and G. Orive Perspectives and challenges in regenerative medicine using plasma rich in growth factors J. Control. Release Jul 8 2011 [Epub ahead of print]
15. P. Tayapongsak, D.A. O'Brien, C.B. Monteiro, and L.Y. Arceo-Diaz Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and marrow J. Oral Maxillofac. Surg. 2 1994 161 165
16. E. Anitua Plasma rich in growth factors: preliminary results of the use in the preparation of future sites for implants Int. J. Oral Maxillofac. Implants 14 1999 529 535
17. M. Leslie Beyond clotting: the powers of platelets Science 328 2010 562 564
18. J.W. Semple, J.E. Italiano Jr., and J. Freedman Platelets and the immune continuum Nat. Rev. Immunology. 11 2011 264 274
19. E. Anitua, I. Andia, B. Ardanza, P. Nurden, and A.T. Nurden Autologous platelets as a source of proteins for healing and tissue regeneration Thromb. Haemost. 91 2004 4 15 (Pubitemid 38111215)
20. J.E. Jr Italiano, J.L. Richardson, S. Patel-Hett, E. Battinelli, A. Zaslavsky, S. Short, S. Ryeom, J. Folkman, and G.L. Klement Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released Blood 111 2008 1227 1233 (Pubitemid 351213404)
21. M. Lesurtel, R. Graf, B. Aleil, D.J. Walther, Y. Tian, W. Jochum, C. Gachet, M. Bader, and P.A. Clavien Platelet-derived serotonin mediates liver regeneration Science 312 2006 104 107
22. Y.Q. Tang, M.R. Yeaman, and M.E. Selsted Antimicrobial peptides from human platelets Infect. Immun. 70 2002 6524 6533 (Pubitemid 35387877)
23. M. Ferrari, S. Zia, M. Valbonesi, F. Henriquet, G. Venere, S. Spagnolo, M.A. Grasso, and I. Panzani A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery Int. J. Artif. Org. 10 1987 47 50 (Pubitemid 17028923)
24. J. Gibble, and P. Ness Fibrin glue: the perfect operative sealant? Transfusion 30 1990 741 747 (Pubitemid 20361794)
25. P.P. Spicer, and A.G. Mikos Fibrin glue as a drug delivery system J. Control. Release 148 2010 49 55
26. E. Anitua, M. Sánchez, G. Orive, and I. Andía The potential impact of the preparation rich in growth factors (PRGF) in different medical fields Biomaterials 28 2007 4551 4560 (Pubitemid 47271893)
27. E. Anitua, G. Orive, J.J. Aguirre, B. Ardanza, and I. Andía 5-year clinical experience with BTI dental implants: risk factors for implant failure J. Clin. Periodontol. 8 2008 724 732
28. L. Engebretsen, K. Steffen, J. Alsousou, E. Anitua, N. Bachl, R. Devilee, P. Everts, B. Hamilton, J. Huard, P. Jenoure, F. Kelberine, E. Kon, N. Maffulli, G. Matheson, O. Mei-Dan, J. Menetrey, M. Philippon, P. Randelli, P. Schamasch, M. Schwellnus, A. Vernec, and G. Verrall IOC consensus paper on the use of platelet-rich plasma in sports medicine Br. J. Sports Med. 15 2010 1072 1081
29. V.R. Driver, J. Hanft, C.P. Fylling, and J.M. Beriou Autologel Diabetic Foot Ulcer Study Group, a prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers Ostomy Wound Manage. 52 2006 68 70
30. A. Hokugo, M. Ozeki, O. Kawakami, K. Sugimoto, K. Mushimoto, S. Morita, and Y. Tabata Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel Tissue Eng. 11 2007 1224 1233
31. M.M. Murray, K.P. Spindler, P. Ballard, T.P. Welch, D. Zurakowski, and L.B. Nanney Enhanced histologic repair in a central wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold J. Orthop. Res. 25 2007 1007 1017 (Pubitemid 47233077)
32. A. Hokugo, T. Takamoto, and Y. Tabata Preparation of hybrid scaffold from fibrin and biodegradable polymer fiber Biomaterials 27 2006 61 67 (Pubitemid 41225369)
33. H. Kitoh, T. Kitakoji, H. Tsuchiya, H. Mitsuyama, H. Nakamura, M. Katoh, and N. Ishiguro Transplantation of marrow-derived mesenchymal stem cells and platelet rich plasma during distraction osteogenesis: a preliminary result of three cases Bone 35 2004 892 898 (Pubitemid 39349220)
34. Y. Liu, Y. Zhou, H. Feng, G.E. Ma, and Y. Ni Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plasma Biomaterials 23 2008 3338 3345
35. L. Formigli, S. Benvenuti, R. Mercatelli, F. Quercioli, A. Tani, C. Mirabella, A. Dama, R. Saccardi, B. Mazzanti, I. Cellai, and S. Zecchi-Orlandini Dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet-rich plasma as a potential tool for tissue repair and regeneration J. Tissue Eng. Regen. Med. Feb 24 2011 10.1002/term.405
36. J.A. Coppinger Moderation of the platelet releasate response by aspirin Blood 109 2007 4786 4792 (Pubitemid 46827772)
37. E. Cenni, G. Ciapetti, D. Granchi, C. Fotia, F. Perut, A. Giunti, and N. Baldini Endothelial cells incubated with platelet-rich plasma express PDGF-B and ICAM-1 and induce bone marrow stromal cell migration J. Orthop. Res. 27 2009 1493 1498
38. E. Ranzato, L. Mazzucco, M. Patrone, and B. Burlando Platelet lysate promotes in vitro wound scratch closure of human dermal fibroblasts: different roles of cell calcium, P38, ERK and PI3K/AKT J. Cell. Mol. Med. 13 2009 2030 2038
39. H.C. de Boer, C. Verseyden, L.H. Ulfman, J.J. Zwaginga, I. Bot, E.A. Biessen, T.J. Rabelink, and A.J. van Zonneveld Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype Arterioscler. Thromb. Vasc. Biol. 26 2006 1653 1659 (Pubitemid 44288997)
40. J. Yamaguchi, K.F. Kusano, O. Masuo, A. Kawamoto, M. Silver, S. Murasawa, M. Bosch-Marce, H. Masuda, D.W. Losordo, J.M. Isner, and T. Asahara Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization Circulation 107 2003 1322 1328 (Pubitemid 36314418)
41. Y. Kajikawa, T. Morihara, H. Sakamoto, K. Matsuda, Y. Oshima, A. Yoshida, M. Nagae, Y. Arai, M. Kawata, and T. Kubo Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing J. Cell. Physiol. 215 2008 837 845 (Pubitemid 351632705)
42. E. Anitua, M. Sanchez, A.T. Nurden, M. Zalduendo, M. de la Fuente, G. Orive, J. Azofra, and I. Andia Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities J. Biomed. Mater. Res. A 77 2006 285 293 (Pubitemid 47233530)
43. M. Sánchez, E. Anitua, J. Azofra, I. Andía, S. Padilla, and I. Mujika Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices Am. J. Sports Med. 35 2007 245 251 (Pubitemid 46145405)
44. J. Zhang, and J.H. Wang Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes Am. J. Sports Med. 38 2010 2477 2486
45. E. Anitua, I. Andía, M. Sanchez, J. Azofra, M. del Mar Zalduendo, M. de la Fuente, P. Nurden, and A.T. Nurden Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture J. Orthop. Res. 23 2005 281 286 (Pubitemid 40287850)
46. H. El-Sharkawy, A. Kantarci, J. Deady, H. Hasturk, H. Liu, M. Alshahat, and T.E. Van Dyke Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties J. Periodontol. 78 2007 661 669
47. P. Bendinelli, E. Matteucci, G. Dogliotti, M.M. Corsi, G. Banfi, P. Maroni, and M.A. Desiderio Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF J. Cell. Physiol. 225 2010 757 766
48. S. Ghosh, and M.S. Hayden New regulators of NF-κB in inflammation Nat. Rev. Immunol. 8 2010 837 847
49. K. Ito, Y. Yamada, T. Nagasaka, H. Baba, and M. Ueda Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-Oss®), platelet rich plasma, and tissue engineered bone with respect to their mechanical properties and histological findings J. Biomed. Mater. Res. A 73 2005 63 72 (Pubitemid 40354824)
50. Y. Yamada, M. Ueda, H. Hibi, and T. Nagasaka Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and platelet rich plasma: form basic research to clinical case study Cell Transplant. 13 2004 343 355 (Pubitemid 39163079)
51. H. Kitoh, T. Kitakoji, H. Tsuchiya, H. Mitsuyama, H. Nakamura, M. Katoh, and N. Ishiguro Transplantation of marrow-derived mesenchymal stem cells and platelet rich plasma during distraction osteogenesis: a preliminary result of three cases Bone 35 2004 892 898 (Pubitemid 39349220)
52. Y. Liu, Y. Zhou, H. Feng, G. Mab, and Y. Ni Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plasma Biomaterials 29 2008 3338 3345